Comparable Effects of Alendronate and Strontium Ranelate on Femur in Ovariectomized Rats

Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: The fracture intervention trial

(2012) Meghan G Donaldson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Teriparatide [rhPTH (1-34)], But Not Strontium Ranelate, Demonstrated Bone Anabolic Efficacy in Mature, Osteopenic, Ovariectomized Rats

(2011) Yanfei L. Ma et al.   ENDOCRINOLOGY

Low-magnitude high-frequency loading via whole body vibration enhances bone-implant osseointegration in ovariectomized rats

(2011) BaiLing Chen et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Femoral metaphysis bending test of rat: introduction and validation of a novel biomechanical testing protocol for osteoporosis

(2011) BaiLing Chen et al.   JOURNAL OF ORTHOPAEDIC SCIENCE

Osteoporosis: now and the future

(2011) Tilman D Rachner et al.   LANCET

A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis

(2011) R. Rizzoli et al.   OSTEOPOROSIS INTERNATIONAL

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats

(2011) Yan Wang et al.   Journal of Orthopaedic Surgery and Research

Effects of Alendronate and Strontium Ranelate on Cancellous and Cortical Bone Mass in Glucocorticoid-Treated Adult Rats

(2010) P. Sun et al.   CALCIFIED TISSUE INTERNATIONAL

The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats

(2010) J. Gregory Seedor et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Management of osteoporosis in postmenopausal women

(2010) &NA;   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis

(2010) René Rizzoli et al.   RHEUMATOLOGY INTERNATIONAL

A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis

(2009) Hiroshi Hagino et al.   BONE

Efficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis

(2009) Jian-Min Liu et al.   BONE

Osteoblasts play key roles in the mechanisms of action of strontium ranelate

(2009) TC Brennan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of strontium ranelate, raloxifene and misoprostol on bone mineral density in ovariectomized rats

(2009) Nefise Ahmet-Camcioglu et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms

(2008) Joseph Caverzasio   BONE

Bone Resorption Inhibitor Alendronate Normalizes the Reduced Bone Thickness of TRPV5−/−Mice

(2008) Tom Nijenhuis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

High Physiological Prolactin Induced by Pituitary Transplantation Decreases BMD and BMC in the Femoral Metaphysis, but Not in the Diaphysis of Adult Female Rats

(2008) Kanogwun Thongchote et al.   Journal of Physiological Sciences

Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response

(2008) G. J. Atkins et al.   OSTEOPOROSIS INTERNATIONAL

Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants

(2008) S. D. Bain et al.   OSTEOPOROSIS INTERNATIONAL

Strontium ranelate does not stimulate bone formation in ovariectomized rats

(2008) R. K. Fuchs et al.   OSTEOPOROSIS INTERNATIONAL

Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro

(2007) Edith Bonnelye et al.   BONE